The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Sizova O.V.

Tver State Medical University, Ministry of Health of Russia, Tver, Russia

Rad'kov O.V.

Tverskaia gosudarstvennaia meditsinskaia akademiia

Kolbasnikov S.V.

Tver State Medical University, Ministry of Health of Russia, Tver, Russia

Paramonova E.K.

Tver State Medical University, Ministry of Health of Russia, Tver, Russia

Chronic hypertension in pregnant women: prognosis and prevention of pregnancy complications; antihypertensive therapy policy

Authors:

Sizova O.V., Rad'kov O.V., Kolbasnikov S.V., Paramonova E.K.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2018;18(6): 25‑30

DOI: 10.17116/rosakush20181806125

Read: 10728 times

Download PDF (RU)
Contact the author
Table of contents

CHRONIC HYPERTENSION IN PREGNANT WOMEN: PROGNOSIS AND PREVENTION OF PREGNANCY COMPLICATIONS; ANTIHYPERTENSIVE THERAPY POLICY
CHRONIC HYPERTENSION IN PREGNANT WOMEN: PROGNOSIS AND PREVENTION OF PREGNANCY COMPLICATIONS; ANTIHYPERTENSIVE THERAPY POLICY

To cite this article:

Sizova OV, Rad'kov OV, Kolbasnikov SV, Paramonova EK. Chronic hypertension in pregnant women: prognosis and prevention of pregnancy complications; antihypertensive therapy policy. Russian Bulletin of Obstetrician-Gynecologist. 2018;18(6):25‑30. (In Russ.)
https://doi.org/10.17116/rosakush20181806125

 
Подписка 2026 Российский вестник акушера-гинеколога (Russian Bulletin of Obstetrician-Gynecologist)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

The literature review presents the data of studies of the course and management of chronic hypertension in pregnant women, by summarizing the works published over the past 11 years. Chronic hypertension has been shown to complicate up to 5% of pregnancies. There is growing evidence that the incidence of chronic hypertension has been rising with increasing maternal age. Adverse pregnancy outcomes are common in this type of hypertension, and it is important to optimize antenatal monitoring and to predict and prevent pregnancy complications. There is a need for a consistent strategy to continue studying the characteristics of pregnancy in the presence of chronic hypertension, since the results of previous studies are contradictory. The result of this study should contribute to the better efficiency of antihypertensive therapy and management in pregnant women with chronic hypertension and to improved pregnancy outcomes for the mother and newborn.

Keywords:

chronic hypertension
pregnancy
risk factors
antihypertensive therapy

Authors:

Sizova O.V.

Tver State Medical University, Ministry of Health of Russia, Tver, Russia

Rad'kov O.V.

Tverskaia gosudarstvennaia meditsinskaia akademiia

Kolbasnikov S.V.

Tver State Medical University, Ministry of Health of Russia, Tver, Russia

Paramonova E.K.

Tver State Medical University, Ministry of Health of Russia, Tver, Russia

Close metadata

References:

  1. Guedes-Martins L. Chronic hypertension and pregnancy. Adv Exp Med Biol. 2017;956:395-407. https://doi.org/10.1007/5584_2016_81
  2. Roberts JM, August PA, Bakris G, Barton JR, Bernstein IM, Druzin M, Gaiser RR, Granger JP, Jeyabalan A, Johnson DD, Karumanchi S, Lindheimer M, Owens MY, Saade GR, Sibai BM, Tsigas E, Joseph GF, O’Reilly N, Politzer A, Son S, Ngaiza K. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obst Gynecol. 2013;122:1122-1131. https://doi.org/10.1097/01.AOG.0000437382.03963.88
  3. Lecarpentier E, Tsatsaris V, Goffinet F, Cabrol D, Sibai B, Haddad B. Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated before pregnancy. PLoS One. 2013;8:5:e62140. https://doi.org/10.1371/journal.pone.0062140
  4. Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014;348:g2301. https://doi.org/10.1136/bmj.g2301
  5. Diagnosis and treatment of cardiovascular diseases during pregnancy 2018. National guidelines. Rossiiskii kardiologicheskii zhurnal. 2018;155:3: 91-134. (In Russ.) https://doi.org/10.15829/1560-4071-2018-3-91-134
  6. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:7: 1281-1357. https://doi.org/10.1097/01.hjh.0000431740.32696.cc
  7. Broekhuijsen K, Ravelli AC, Langenveld J, van Pampus MG, van den Berg PP, Mol BW, Franssen MT. Maternal and neonatal outcomes of pregnancy in women with chronic hypertension: a retrospective analysis of a national register. Acta Obstet Gynecol Scand. 2015;94:12:1337-1345. https://doi.org/10.1111/aogs.12757
  8. Keskinkılıç B, Engin-Üstün Y, Sanisoğlu S, Şahin Uygur D, Keskin HL, Karaahmetoğlu S, Özcan A, Esen M, Alkan A, Kabasakal A, Şencan I. Maternal mortality due to hypertensive disorders in pregnancy, childbirth, and the puerperium between 2012 and 2015 in Turkey: A nation-based study. J Turk Ger Gynecol Assoc. 2017; 18:1:20-25. https://doi.org/10.4274/jtgga.2016.0244
  9. Ambia AM, Morgan JL, Wells CE, Roberts SW, Sanghavi M, Nelson DB, Cunningham FG. Perinatal outcomes associated with abnormal cardiac remodeling in women with treated chronic hypertension. Am J Obstet Gynecol. 2018;218:5:519-526. https://doi.org/10.1016/j.ajog.2018.02.015
  10. Ambia AM, Morgan JL, Wilson KL, Roberts SW, Wells CE, McIntire DD, Sanghavi M, Nelson DB, Cunningham FG. Frequency and consequences of ventricular hypertrophy in pregnant women with treated chronic hypertension. Am J Obstet Gynecol. 2017; 217:4:467.e1-e467.e6. https://doi.org/10.1016/j.ajog.2017.05.061
  11. Yee LM, Caughey AB, Cheng YW. Association between gestational weight gain and perinatal outcomes in women with chronic hypertension. Am J Obstet Gynecol. 2017;217:3:348-357. https://doi.org/10.1016/j.ajog.2017.05.016
  12. Ananth CV, Peltier MR, Kinzler WL, Smulian JC, Vintzileos AM. Chronic hypertension and risk of placental abruption: is the association modified by ischemic placental disease? Am J Obstet Gynecol. 2007;197:3:273-280. https://doi.org/10.1016/j.ajog.2007.05.047
  13. Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension. 2008;51:4:1002-1009. https://doi.org/10.1161/HYPERTENSIONAHA.107.107565
  14. Wang Y, Li M, Xie BJ, Guo PG, Cheng YP, Feng YL, Zhang P, Wu WW, Wang SP, Zhang YW, Yang HL. Influence of hypertension disorder complicating pregnancy and its interaction with other factors on incidence of small for gestational age. Zhonghua Liu Xing Bing Xue Za Zhi. 2016;37:9:1283-1287. https://doi.org/10.3760/cma.j.issn.0254-6450.2016.09.020
  15. Sun Y, Yang YL, Yang HX. Maternal and perinatal prognosis of pregnancy with chronic hypertension and analysis of associated factors. Zhonghua Fu Chan Ke Za Zhi. 2007;42:7:434-437. PMID: 17961329
  16. Gasse C, Boutin A, Demers S, Chaillet N, Bujold E. Body mass index and the risk of hypertensive disorders of pregnancy: the great obstetrical syndromes (GOS) study. J Matern Fetal Neonatal Med. 2017;13:1-6. https://doi.org/10.1080/14767058.2017.1399117
  17. Siegel AM, Tita AT, Machemehl H, Biggio JR, Harper LM. Evaluation of institute of medicine guidelines for gestational weight gain in women with chronic hypertension. AJP Rep. 2017;7:3:145-150. https://doi.org/10.1055/s-0037-1604076
  18. Muto H, Yamamoto R, Ishii K, Kakubari R, Takaoka S, Mabuchi A, Mitsuda N. Risk assessment of hypertensive disorders in pregnancy with maternal characteristics in early gestation: a single-center cohort study. Taiwan J Obstet Gynecol. 2016;55:341-345. https://doi.org/10.1016/j.tjog.2016.04.009
  19. Poon LC, Wright D, Rolnik DL, Syngelaki A, Delgado JL, Tsokaki T, Leipold G, Akolekar R, Shearing S, De Stefani L, Jani JC, Plasencia W, Evangelinakis N, Gonzalez-Vanegas O, Persico N, Nicolaides KH. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol. 2017;217:5:585-590. https://doi.org/10.1016/j.ajog.2017.07.038
  20. Visser VS, Hermes W, Twisk J, Franx A, van Pampus MG, Koopmans C, de Groot CJM. Prognostic model for chronic hypertension in women with a history of hypertensive pregnancy disorders at term. Pregnancy Hypertens. 2017;10:118-123. https://doi.org/10.1016/j.preghy.2017.07.141
  21. Logutova LS, Tsivtsivadze EB, Petrukhin VA, Gur’eva VM, Kapustina MV, Akhvlediani KN, Kovalenko TS. Role of 24-hour blood pressure monitoring in the prevention of gestosis. Rossiiskii vestnik akushera-ginekologa. 2007;7:5:39-43. (In Russ.)
  22. Rozhdestvenskaya TA. Prognostic significance of blood pressure values 24-hour monitoring for pregnancy course and outcome. Zdravookhranenie. 2013;7:59-63. (In Russ.)
  23. Ayala DE, Hermida RC. Ambulatory blood pressure monitoring for the early identification of hypertension in pregnancy. Chronobiol Int. 2013;30:233-259. https://doi.org/10.3109/07420528.2012.714687
  24. Gur’eva VM, Petrukhin VA, Sidorova AA, Kholdina MA, Kotov YuB. The effectiveness of antihypertensive therapy in pregnant women. Lechenie i profilaktika. 2013;6:2:77-82. (In Russ.)
  25. Chulkov VS, Vereina NK, Sinitsyn SP, Dolgushina VF. Estimation of central blood pressure and arterial stiffness in pregnant women with different forms of hypertension. Terapevticheskii arkhiv. 2014;86:12:15-19. (In Russ.) https://doi.org/10.17116/terarkh2014861215-19
  26. Boriboonhirunsarn D, Pradyachaipimol A, Viriyapak B. Incidence of superimposed preeclampsia among pregnant Asian women with chronic hypertension. Hypertens Pregnancy. 2017;36:2:226-231. https://doi.org/10.1080/10641955.2017.1311340
  27. Panaitescu AM, Roberge S, Nicolaides KH. Chronic hypertension: effect of blood pressure control on pregnancy outcome. J Matern Fetal Neonatal Med. 2017;1:1-7. https://doi.org/10.1080/14767058.2017.1390742
  28. Alekseeva LL. The main indicators of 24-hour monitoring of blood pressure in pregnant Russian and Buryat populations with hypertension. Vrach-aspirant. 2011;3:77-81. (In Russ.)
  29. Li OA. Clinical relevance of ambulatory blood pressure monitoring in women with metabolic syndrome in II trimester of pregnancy. Klinitsist. 2011;2:31-35. (In Russ.)
  30. Ilic A, Ilic DJ, Tadic S, Stefanovic M, Stojsic-Milosavljevic A, Pavlovic K, Redzek A, Velicki L. Influence of non-dipping pattern of blood pressure in gestational hypertension on maternal cardiac function, hemodynamics and intrauterine growth restriction. Pregnancy Hypertens. 2017;10:34-41. https://doi.org/10.1016/j.preghy.2017.05.003
  31. Meher S, Duley L, Hunter K, Askie L. Antiplatelet therapy before or after 16 weeks’ gestation for preventing preeclampsia: an individual participant data meta-analysis. Am J Obstet Gynecol. 2017; 216:2:121-128. https://doi.org/10.1016/j.ajog.2016.10.016
  32. Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and meta-analysis. Am J Obstet Gynecol. 2018;218:3:287-293. https://doi.org/10.1016/j.ajog.2017.11.561
  33. Cui Y, Zhu B, Zheng F. Low-dose aspirin at ≤16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: a systematic review and meta-analysis. Exp Ther Med. 2018;15:5:4361-4369. https://doi.org/10.3892/etm.2018.5972
  34. Wright D, Rolnik DL, Syngelaki A, de Paco Matallana C, Machuca M, de Alvarado M, Mastrodima S, Tan MY, Shearing S, Persico N, Jani JC, Plasencia W, Papaioannou G, Molina FS, Poon LC, Nicolaides KH. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit. Am J Obstet Gynecol. 2018;218:6:612.e1-612.e6. https://doi.org/10.1016/j.ajog.2018.02.014
  35. Roberge S, Bujold E, Nicolaides KH. Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage. Am J Obstet Gynecol. 2018;218: 5:483-489. https://doi.org/10.1016/j.ajog.2017.12.238
  36. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC, Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology / American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017;00:e000-e000. https://doi.org/10.1161/HYP.0000000000000065
  37. Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens. 2014;4:2:105-145. https://doi.org/10.1016/j.preghy.2014.01.003
  38. Cea Soriano L, Bateman BT, García Rodríguez LA, Hernández-Díaz S. Prescription of antihypertensive medications during pregnancy in the UK. Pharmacoepidemiol Drug Saf. 2014;23:10:1051-1058. https://doi.org/10.1002/pds.3641
  39. Seguro F, Duly Bouhanick B, Chamontin B, Amar J. Management of arterial hypertension before 20 weeks gestation in pregnant women. Presse Med. 2016;45:7-8:1:627-630. https://doi.org/10.1016/j.lpm.2016.06.008
  40. Firoz T, Magee LA, MacDonell K, Payne BA, Gordon R, Vidler M, von Dadelszen P. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. BJOG. 2014;121:10:1210-1218. https://doi.org/10.1111/1471-0528.12737
  41. Cleary KL, Siddiq Z, Ananth CV, Wright JD, Too G, DʼAlton ME, Friedman AM. Use of antihypertensive medications during delivery hospitalizations complicated by preeclampsia. Obstet Gynecol. 2018; 131:3:441-450. https://doi.org/10.1097/AOG.000000000002479
  42. Webster LM, Conti-Ramsden F, Seed PT, Webb AJ, Nelson-Piercy C, Chappell LC. Impact of antihypertensive treatment on maternal and perinatal outcomes in pregnancy complicated by chronic hypertension: a systematic review and meta-analysis. J Am Heart Assoc. 2017;6:5:e005526. https://doi.org/10.1161/JAHA.117.005526
  43. Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2014;2:CD002252. https://doi.org/10.1002/14651858.CD002252.pub3
  44. Rezk M, Ellakwa H, Gamal A, Emara M. Maternal and fetal morbidity following discontinuation of antihypertensive drugs in mild to moderate chronic hypertension: A 4-year observational study. Pregnancy Hypertens. 2016;6:4:291-294. https://doi.org/10.1016/j.preghy.2016.05.002
  45. Jiang N, Liu Q, Liu L, Yang WW, Zeng Y. The effect of calcium channel blockers on prevention of preeclampsia in pregnant women with chronic hypertension. Clin Exp Obstet Gynecol. 2015;42:1:79-81. PMID: 25864288
  46. Vidler M, Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Singer J, Gafni A, Gruslin A, Helewa M, Hutton E, Lee SK, Lee T, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM. Women’s views and postpartum follow-up in the CHIPS Trial (Control of Hypertension in Pregnancy Study). Eur J Obstet Gynecol Reprod Biol. 2016;206:105-113. https://doi.org/10.1016/j.ejogrb.2016.07.509
  47. Magee LA, Singer J, von Dadelszen P. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372:24: 2367-2368. https://doi.org/10.1056/NEJMc1503870
  48. Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Helewa M, Hutton E, Koren G, Lee SK, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM. The CHIPS randomized controlled trial (control of hypertension in pregnancy study): is severe hypertension just an elevated blood pressure? Hypertension. 2016;68:5: 1153-1159. https://doi.org/10.1161/HYPERTENSIONAHA.116.07862
  49. Nabhan AF, Elsedawy MM. Tight control of mild-moderate pre-existing or non-proteinuric gestational hypertension. Cochrane Database Syst Rev. 2011;7:CD006907. https://doi.org/10.1002/14651858.CD006907.pub2
  50. Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Gruslin A, Helewa M, Hutton E, Koren G, Lee SK, Logan AG, Welch R, Thornton JG, Moutquin JM. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa? BJOG. 2016; 123:7:1135-1141. https://doi.org/10.1111/1471-0528
  51. Nzelu D, Dumitrascu-Biris D, Nicolaides KH, Kametas NA. Chronic hypertension: first-trimester blood pressure control and likelihood of severe hypertension, preeclampsia and small for gestational age. Am J Obstet Gynecol. 2018;218:3:337-344. https://doi.org/10.1016/j.ajog.2017.12.235
  52. Mikhailova OO, Litvin AYu, Rogoza AN. Influence of modifiable cardiovascular risk factors on antihypertensive therapy efficiency escape. Terapevticheskii arkhiv. 2017;89:9:10-14. (In Russ.) https://doi.org/10.17116/terarkh201789910-14
  53. Chulkov VS, Vereina NK, Sinitsyn SP, Dolgushina VF. Evaluation of an interrelation of target blood pressure achievement and complications and outcomes of pregnancy in arterial hypertension. Kardiovaskulyarnaya terapiya i profilaktika. 2014;13:6:23-27. (In Russ.) https://doi.org/10.15829/1728-8800-2014-6-23-27
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.